A phase I trial of concurrent chemoradiotherapy with non-split administration of docetaxel and cisplatin for dry stage III non-small-cell lung cancer (JCOG9901DI)

PURPOSE: This study aimed to establish the maximum tolerated dose of concurrent chemoradiotherapy (cCRT) with conventional administration of the docetaxel (D) plus cisplatin (P) (conv-DP) regimen. METHODS: Patients (aged ≤70 years) with unresectable dry stage III non-small-cell lung cancer (NSCLC) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hida, Naoya, Okamoto, Hiroaki, Misumi, Yuuki, Sato, Akira, Ishii, Mari, Kashizaki, Fumihiro, Shimokawa, Tsuneo, Shimizu, Teppei, Watanabe, Koshiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3362714/
https://www.ncbi.nlm.nih.gov/pubmed/22565592
http://dx.doi.org/10.1007/s00280-012-1871-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3362714/
https://www.ncbi.nlm.nih.gov/pubmed/22565592
http://dx.doi.org/10.1007/s00280-012-1871-5

Ejemplares similares